CYP2D6 genetic variation in Ugandans

Eur J Clin Pharmacol. 2022 Jan;78(1):155-157. doi: 10.1007/s00228-021-03208-8. Epub 2021 Aug 27.

Jun Miura^{1

2}, Celestino Obua³, Catherine Abbo⁴, Tomonori Tateishi⁵, Sunao Kaneko⁶

¹ Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. junmiura0815@med.showa-u.ac.jp.
² Department of Clinical Pharmacology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. junmiura0815@med.showa-u.ac.jp.
³ Department of Pharmacology and Therapeutics, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.
⁴ Department of Psychiatry, College of Health Sciences, Makerere University, Kampala, Uganda.
⁵ Department of Clinical Pharmacology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
⁶ Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

No abstract available

Keywords: Africa; Cytochrome P450 2D6 (CYP2D6); Genetic variation; Poor metaboliser; Uganda; Ultrarapid metaboliser.

Publication types